Literature DB >> 11606424

Temporal relationship between the sexually dimorphic spontaneous GH secretory profiles and hepatic STAT5 activity.

G S Tannenbaum1, H K Choi, W Gurd, D J Waxman.   

Abstract

STAT5 transduces transcriptional responses to GH in liver and other tissues and is proposed to mediate the sexually dimorphic effects of plasma GH secretory profiles on rodent liver gene expression. Previous studies have suggested that STAT5 undergoes repeated activation in direct response to successive GH pulses in adult male rats, with STAT5 activation being desensitized in females by their more persistent pattern of GH exposure. These findings, however, were based on in vitro studies or single blood samples analyzed for GH in vivo. In view of the highly pulsatile nature of rat GH secretion, we presently examined these hypotheses by concurrent monitoring of spontaneous GH secretory profiles and hepatic STAT5 activity in conscious, free-moving adult male and female rats. Rats were killed at times associated with spontaneous peaks or troughs of the GH rhythm; livers were removed and analyzed for STAT5 DNA-binding activity. In males, liver STAT5 activity was highest during the initial phase (15-60 min) of a GH secretory episode (mean +/- SE relative STAT5 activity = 86.5 +/- 11.4; plasma GH = 146.7 +/- 22.4 ng/ml) and was significantly lower (P < 0.01) during the downswing of a pulse, 45-75 min after the GH peak (STAT5 = 26.1 +/- 1.7; GH = 33.3 +/- 13.1 ng/ml), consistent with a time-dependent down-regulation of GH signaling to STAT5. The lowest STAT5 activity was observed during the subsequent GH trough period (STAT5 = 3.6 +/- 1.1; GH = 2.6 +/- 0.1 ng/ml). In females, liver STAT5 activity was significantly lower (P < 0.05) than peak male levels during the initial phase of a GH secretory burst (STAT5 = 35.1 +/- 15.9; GH = 68.1 +/- 31.6 ng/ml) although similar to that of males during a plasma GH nadir (STAT5 = 11.0 +/- 2.6; GH = 8.4 +/- 2.2 ng/ml). We conclude that: 1) liver STAT5 is repeatedly activated by successive, spontaneous GH secretory episodes in intact adult male rats at approximately 3- to 3.5-h intervals; 2) time-dependent down-regulation of GH signaling to hepatic STAT5 in vivo begins by 45 min after GH peak stimulation; and 3) the lower level of liver STAT5 activation seen in adult female rats, compared with males, is a consequence of the sex-dependent differences in GH secretory patterns that characterize these animals (i.e. lower-amplitude GH pulses and lack of prolonged interpulse nadir of GH in the feminine, compared with masculine profile).

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11606424     DOI: 10.1210/endo.142.11.8480

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  31 in total

1.  Sex differences in thrombosis in mice are mediated by sex-specific growth hormone secretion patterns.

Authors:  Joshua H Wong; Jonathan Dukes; Robert E Levy; Brandon Sos; Sara E Mason; Tina S Fong; Ethan J Weiss
Journal:  J Clin Invest       Date:  2008-08       Impact factor: 14.808

Review 2.  The role of liver-derived insulin-like growth factor-I.

Authors:  Claes Ohlsson; Subburaman Mohan; Klara Sjögren; Asa Tivesten; Jörgen Isgaard; Olle Isaksson; John-Olov Jansson; Johan Svensson
Journal:  Endocr Rev       Date:  2009-07-09       Impact factor: 19.871

3.  Sex-specific early growth hormone response genes in rat liver.

Authors:  Valerie Wauthier; David J Waxman
Journal:  Mol Endocrinol       Date:  2008-05-15

4.  Impact of CUX2 on the female mouse liver transcriptome: activation of female-biased genes and repression of male-biased genes.

Authors:  Tara L Conforto; Yijing Zhang; Jennifer Sherman; David J Waxman
Journal:  Mol Cell Biol       Date:  2012-09-10       Impact factor: 4.272

5.  Revealing the large-scale network organization of growth hormone-secreting cells.

Authors:  Xavier Bonnefont; Alain Lacampagne; Angela Sanchez-Hormigo; Elodie Fino; Audrey Creff; Marie-Noelle Mathieu; Sébastien Smallwood; Danielle Carmignac; Pierre Fontanaud; Pierre Travo; Gérard Alonso; Nathalie Courtois-Coutry; Steve M Pincus; Iain C A F Robinson; Patrice Mollard
Journal:  Proc Natl Acad Sci U S A       Date:  2005-11-04       Impact factor: 11.205

6.  Signalling cross-talk between hepatocyte nuclear factor 4alpha and growth-hormone-activated STAT5b.

Authors:  Soo-Hee Park; Christopher A Wiwi; David J Waxman
Journal:  Biochem J       Date:  2006-07-01       Impact factor: 3.857

7.  Hepatocellular alterations and dysregulation of oncogenic pathways in the liver of transgenic mice overexpressing growth hormone.

Authors:  Johanna G Miquet; Thomas Freund; Carolina S Martinez; Lorena González; María E Díaz; Giannina P Micucci; Elsa Zotta; Ravneet K Boparai; Andrzej Bartke; Daniel Turyn; Ana I Sotelo
Journal:  Cell Cycle       Date:  2013-02-21       Impact factor: 4.534

8.  Hypothesis: Neuroendocrine Mechanisms (Hypothalamus-Growth Hormone-STAT5 Axis) Contribute to Sex Bias in Pulmonary Hypertension.

Authors:  Pravin B Sehgal; Yang-Ming Yang; Edmund J Miller
Journal:  Mol Med       Date:  2015-07-30       Impact factor: 6.354

9.  The decrease in mature myostatin protein in male skeletal muscle is developmentally regulated by growth hormone.

Authors:  Jenny M Oldham; Claire C Osepchook; Ferenc Jeanplong; Shelley J Falconer; Kenneth G Matthews; John V Conaglen; David F Gerrard; Heather K Smith; Richard J Wilkins; James J Bass; Christopher D McMahon
Journal:  J Physiol       Date:  2008-12-01       Impact factor: 5.182

10.  STAT5 Regulation of Sex-Dependent Hepatic CpG Methylation at Distal Regulatory Elements Mapping to Sex-Biased Genes.

Authors:  Pengying Hao; David J Waxman
Journal:  Mol Cell Biol       Date:  2021-01-25       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.